Comparative Ribosome Analysis of Pseudomonas aeruginosa Planktonic and Biofilm Cells
Abstract
Full Text:
PDFReferences
Anderson, M., R. Gregory, S. Thompson, D. Souza, S. Paul, R. Mulligan, A. Smith, and M. Welsh. 1991. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253:202-205.
Bjarnsholt, T., P. Ø. Jensen, M. J. Fiandaca, J. Pedersen, C. R. Hansen, C. B. Andersen, T. Pressler, M. Givskov, and N. Høiby. 2009. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatric Pulmonology 44:547-558.
Cho, J., J. Rogers, M. Kearns, M. Leslie, S. D. Hartson, and K. S. Wilson. 2015. Escherichia coli persister cells suppress translation by selectively disassembling and degrading their ribosomes. Molecular Microbiology 95:352-364.
Drenkard, E. 2003. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 5:1213-1219.
Folkesson, A., L. Jelsbak, L. Yang, H. K. Johansen, O. Ciofu, N. Hoiby, and S. Molin. 2012. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nature Reviews Micro 10:841-851.
Fosso, M. Y., H. Zhu, K. D. Green, S. Garneau‐Tsodikova, and K. Fredrick. 2015. Tobramycin Variants with Enhanced Ribosome‐Targeting Activity. ChemBioChem 16:1565-1570.
Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiological Reviews 60:539-574.
Hall-Stoodley, L., J. W. Costerton, and P. Stoodley. 2004. Bacterial biofilms: from the Natural environment to infectious diseases. Nature Reviews Micro 2:95-108.
Hoffman, L. R., D. A. D'Argenio, M. J. MacCoss, Z. Zhang, R. A. Jones, and S. I. Miller. 2005. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436:1171-1175.
O'Sullivan, B. P., and S. D. Freedman. 2009. Cystic fibrosis. The Lancet 373:1891-1904.
Potrykus, K., and M. Cashel. 2008. (p)ppGpp: still magical? Annual Review of Microbiology 62:35-51.
Ramsey, B. W., H. L. Dorkin, J. D. Eisenberg, R. L. Gibson, I. R. Harwood, R. M. Kravitz, D. V. Schidlow, R. W. Wilmott, S. J. Astley, and M. A. McBurnie. 1993. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. New England Journal of Medicine 328:1740-1746.
Ratjen, F., G. Döring, and W. H. Nikolaizik. 2001. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. The Lancet 358:983-984.
Walters, M. C., F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrobial Agents And Chemotherapy 47:317-323.
Yoshida, H., Y. Maki, H. Kato, H. Fujisawa, K. Izutsu, C. Wada, and A. Wada. 2002. The ribosome modulation factor (RMF) binding site on the 100S ribosome of Escherichia coli. Journal of Biochemistry 132:983-989.
Refbacks
- There are currently no refbacks.